Skip to main content
Clinical Trials/NCT02815085
NCT02815085CompletedNot Applicable

Pilot to Assess Feasibility of Using RecoverLINK Technology to Supplement Outpatient Care for Heart Failure Patients

RecoverLINK1 site in 1 country46 target enrollmentStarted: February 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
46
Locations
1
Primary Endpoint
User engagement: # symptom surveys completed/30 days

Study Overview

Brief Summary

The primary objective is to examine feasibility of incorporating RecoverLINK into the standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii) workflow efficiency. As secondary objectives, the investigators will collect preliminary data to examine the association between patient engagement with the RecoverLINK app and (i) changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and 90-day time periods post-enrollment.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Heart failure (HF) patients with a rapid follow up appointment scheduled at the Mount Sinai HF clinic
  • •English-speaking
  • •With either access to (i) an iOS smart device or (ii) wifi at-home

Exclusion Criteria

  • •Patients meeting any of the following criteria:
  • •A heart transplant
  • •A mechanical circulatory support (MCS) device
  • •An altered mental status
  • •Serious co-morbidities (as identified by Mount Sinai team)
  • •Cognitive impairments (as identified by Mount Sinai team)
  • •Inability to use technology (as identified by Mount Sinai team)

Arms & Interventions

RecoverLINK technology

Experimental

RecoverLINK is a two-part mHealth technology designed to supplement traditional care transitional programs for heart failure (HF) patients.

Intervention: RecoverLINK technology (Other)

Outcomes

Primary Outcomes

User engagement: # symptom surveys completed/30 days

Time Frame: 30 days

User satisfaction: Percent patients report "satisfied" via post-program survey

Time Frame: 30 days

Workflow efficiency: mean/median time to resolution of patient alerts

Time Frame: 30 days

Secondary Outcomes

  • Hospital admission(30, 60, 90 days)
  • Mean difference in pre/post SCHIFI score(30 days)

Investigators

Sponsor
RecoverLINK
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials